3 unknown, 2 recruiting, 1 completed, 1 withdrawn. 5 Phase 4, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Recruiting 2, Completed 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Shenzhen Ausa Pharmed Co.,Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT) Amlodipine besylate, Amlodipine besylate and folic acid, Amlodipine placebos - Hypertension, MTHFR 677 CC or CT Genotype | Phase 4 | Recruiting | Shenzhen Ausa Pharmed Co.,Ltd | 32000 | 2024-08-22 | 2025-02-26 |
| China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype Amlodipine besylate, Amlodipine besylate And Folic Acid, 5-methyltetrahydrofolate (5-MTHF) - Hypertension, MTHFR 677 TT Genotype | Phase 4 | Recruiting | Shenzhen Ausa Pharmed Co.,Ltd | 24000 | 2024-08-22 | 2025-02-26 |
| H-Type Hypertension Precision Medicine Trial Folic Acid, Enalapril Maleate and Folic Acid Tablets (Yiye), Enalapril - Hypertension | Phase 4 | Unknown | Shenzhen Ausa Pharmed Co.,Ltd | 3600 | 2018-03-20 | 2018-07-18 |
| Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Amlodipine-FA tablet,low dose group, Amlodipine-FA tablet,high dose group, Amlodipine - Essential Hypertension | Phase 2 / Phase 3 | Unknown | Shenzhen Ausa Pharmed Co.,Ltd | 540 | 2013-09-01 | 2013-10-08 |
| Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Amlodipine, amlodipine-FA tablet, low dose group, amlodipine-FA tablet ,high dose group - Essential Hypertension | Phase 2 / Phase 3 | Unknown | Shenzhen Ausa Pharmed Co.,Ltd | 756 | 2013-01-01 | 2013-05-08 |
| China Stroke Primary Prevention Trial Enalapril/folic acid, Enalapril maleate - Primary Hypertension | Phase 4 | Completed | Shenzhen Ausa Pharmed Co.,Ltd | 20702 | 2008-05-01 | 2014-08-12 |
| CSPPT- Chronic Kidney Diseases Study Enalapril maleate and folic acid tablets, Enalapril maleate - Hypertension, Hyperhomocysteinemia | Phase 4 | Withdrawn | Shenzhen Ausa Pharmed Co.,Ltd | 2008-05-01 | 2016-01-20 |
Hypertension (6) · Essential Hypertension (3) · Hyperhomocysteinemia (2) · Ischemic Stroke (2) · Renal Insufficiency, Chronic (1) · Stroke (1)
Folic Acid (5) · Amlodipine (4) · Enalapril (3) · Contraceptives, Oral (2) · 5-methyltetrahydrofolate (1) · Population Groups (1)
China (7)
Fanfan Hou, MD (1) · Jianping Li, MD, PhD (1) · Wang Jiguang, MD (1) · Xiaoshu Cheng, MD (1) · Xin Xu, MD (1) · Yong Huo, M.D. (1) · Yong Huo, MD (1) · Yong Huo, MD, PhD (1)
PMID 25771069, PMID 21869730, PMID 22230384, PMID 22880024, PMID 29030456, PMID 22897803, PMID 27834686, PMID 22850357, PMID 26474738, PMID 26991917, PMID 27548766, PMID 27729579, PMID 28122783, PMID 28148501, PMID 28288974, PMID 28360116, PMID 28607125, PMID 29018022, PMID 29273594, PMID 29371246, PMID 29747834, PMID 30354996, PMID 30372582, PMID 30624586, PMID 30713028, PMID 31161196, PMID 31446884, PMID 31462258, PMID 31806397, PMID 33099298, PMID 34549258, PMID 34558624, PMID 34805240, PMID 34930356, PMID 35660920, PMID 35903445, PMID 36083982, PMID 37433173, PMID 37501059, PMID 37781132, PMID 38092871, PMID 38478042, PMID 38683601, PMID 39821957, PMID 41543379, PMID 42861767